Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-05 4:15 pm Purchase |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
WuXi PharmaTech Healthcare Fund I L.P. | 1,000,000 1.600% |
1,000,000 (New Position) |
Filing History |
| 2022-02-08 4:01 pm Purchase |
2021-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
WuXi PharmaTech Healthcare Fund I L.P. | 29,267,687 12.000% |
29,267,687 (New Position) |
Filing History |
| 2022-01-26 06:09 am Purchase |
2021-12-31 | 13G | Adagene Inc. ADAG |
WuXi PharmaTech Healthcare Fund I L.P. | 5,282,120 9.670% |
5,282,120 (New Position) |
Filing History |
| 2021-01-08 4:49 pm Purchase |
2018-12-31 | 13G | Unity Biotechnology, Inc. UBX |
WuXi PharmaTech Healthcare Fund I L.P. | 147,799 2.800% |
147,799 (New Position) |
Filing History |